Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beyond EPO.

Brian Corrigan1

  • 1Institute of Sport, Concord Hospital, Sydney, New South Wales, Australia. abc@southernx.com.au

Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine
|July 20, 2002
PubMed
Summary

Athletes seeking enhanced aerobic performance are exploring novel blood boosters beyond erythropoietin (EPO). Newer hemoglobin oxygen carriers and perfluorocarbons offer alternatives with potentially fewer side effects for improving red blood cell concentration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How Clinical Pharmacology Can Support Clinical Trial Diversity and Inclusion.

Clinical and translational science·2025
Same author

Impact of Model-Informed Drug Development on Drug Development Cycle Times and Clinical Trial Cost.

Clinical pharmacology and therapeutics·2025
Same author

Fishery catch records support machine learning-based prediction of illegal fishing off US West Coast.

PeerJ·2023
Same author

Correction to: Training the next generation of pharmacometric modelers: a multisector perspective.

Journal of pharmacokinetics and pharmacodynamics·2023
Same author

Patient Centric Microsampling to Support Paxlovid Clinical Development: Bridging and Implementation.

Clinical pharmacology and therapeutics·2023
Same author

Training the next generation of pharmacometric modelers: a multisector perspective.

Journal of pharmacokinetics and pharmacodynamics·2023

Area of Science:

  • Sports Science
  • Biochemistry
  • Pharmacology

Background:

  • Erythropoietin (EPO) has been a traditional method for athletes to increase red blood cell concentration and improve aerobic capacity.
  • EPO use is associated with significant drawbacks, including increased blood viscosity and the development of effective drug testing methods.
  • The need for safer and more effective methods to enhance oxygen delivery for athletic performance is evident.

Purpose of the Study:

  • To review emerging compounds designed to boost red blood cell concentration.
  • To evaluate newer alternatives for improving aerobic activities in athletes.
  • To compare the mechanisms and potential benefits of novel oxygen-carrying compounds.

Main Methods:

  • Review of scientific literature on recently developed compounds for red blood cell enhancement.
  • Analysis of the chemical structures and oxygen-carrying capabilities of hemoglobin oxygen carriers and perfluorocarbons.
  • Examination of potential side effects and medical applications of these new compounds.

Main Results:

  • Hemoglobin oxygen carriers are modified hemoglobin molecules designed to reduce complications like renal toxicity.
  • Perfluorocarbons are synthetic compounds incorporating fluorine, facilitating oxygen delivery to tissues.
  • Evidence suggests athletes are already utilizing these advanced molecules to gain performance advantages.

Conclusions:

  • Hemoglobin oxygen carriers and perfluorocarbons represent promising alternatives to EPO for enhancing aerobic performance.
  • These novel compounds offer different mechanisms for oxygen delivery with potentially improved safety profiles.
  • The adoption of these substances by athletes highlights their perceived efficacy in boosting athletic capabilities.

Related Experiment Videos